Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference42 articles.
1. Glioblastoma multiforme: an overview of emerging therapeutic targets;Taylor;Front. Oncol.,2019
2. Molecular characteristics of glioblastoma with 1p/19q co-deletion;Mizoguchi;Brain Tumor Pathol.,2012
3. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients;Gao;J. Transl. Med.,2018
4. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006
5. Advances in stem cell therapy against gliomas;Bovenberg;Trends Mol. Med.,2013
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03
2. Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment;Brain Tumor Pathology;2024-04
3. MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p;Cell Death Discovery;2024-03-14
4. The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme;Cells;2024-01-10
5. Aptamer-functionalized liposomes for drug delivery;Biomedical Journal;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3